FRED NELSON Pharmacokinetics and Drug Metabolism

EDUCATION · BS-Biochemistry

EXPERIENCE · 2015–present BioPharmaWorks, CFO and Director, Pharmacokinetics and DrugMetabolism · 2010–2014 Systamedic–Director,Pharmacokinetics and Drug Metabolism  · 1994–2010 Pfizer-Pharmacokinetics and Drug Metabolism · 1984–1994 Burroughs Wellcome

EXPERTISE · Drug Metabolism, Drug discovery Psychotherapeutics, Neurodegeneration, Allergy,Cancer. Over 30 scientific publications

BIO

Over 20 years experience in a problem-solving role relating to the design, execution and interpretation of all in vitro and in vivo experiments to evaluate the absorption, distribution, metabolism and excretion (ADME) characteristics of new chemical entities (NCE) from hit-to-lead through Phase 2a. Nominated over a dozen clinical candidates in the neuroscience field for indications such as schizophrenia, anxiety/depression, smoking cessation and neurodegeneration.